Testosterone Injectable Market Trends

  • Report ID: 3973
  • Published Date: Nov 20, 2025
  • Report Format: PDF, PPT

Testosterone Injectable Market - Growth Drivers and Challenges

Growth Drivers

  • Rapidly Growing Geriatric Population Across the World – The growth in the aging population is giving rise to the testosterone injectable market expansion of testosterone injectables since testosterone organically reduces with the growing age and a lot of old people experience the symptoms of low testosterone. As per the statistics, the incidence of lower testosterone in men above the age of 60 years was 21.67%.

  • High Incidence of Testosterone Deficiency Among People Globally – Besides the aging population low testosterone can also appear in the younger generation too. Owing to various factors such as obesity, chronic illness, excessive lifestyle change, and environmental factors. The growing existence of testosterone deficiency among different age groups has propelled the demand for testosterone injectables. As per statistics, the prevalence of testosterone in young men, middlemen, and old men was 22.6%, 35.85%, and 35% respectively.

  • Availability to Various Treatment Centers – The accessibility to multiple diagnostics imaging centers, and treatment services in the past few years especially in emerging countries.

Challenges

  • Side Effects Associated with Testosterone Injectables – With advantages testosterone injectables do have a few side effects on the human body such as reduced sperm production, acne, skin reactions, sleep problem, hair loss, mood swings, and others. These side effects may limit the market value in the upcoming times.

  • Availability of Substitute Treatment Options

  • Regulatory Challenges

Base Year

2025

Forecast Year

2026-2035

CAGR

3.9%

Base Year Market Size (2025)

USD 2.3 billion

Forecast Year Market Size (2035)

USD 3.37 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of testosterone injectable is assessed at USD 2.38 billion.

The global testosterone injectable market size was valued at more than USD 2.3 billion in 2025 and is expected to register a CAGR of over 3.9%, exceeding USD 3.37 billion revenue by 2035.

North America is projected to secure the largest revenue share by 2035 in the testosterone injectable market, invigorated by the widespread availability of advanced medical centers and expanding government-led healthcare initiatives.

Key players in the market include Bayer AG, Endo Pharmaceuticals Inc., Eli Lilly & Company, Kyowa Kirin International plc, Mylan N.V., Novartis AG.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos